顯示第 17 至 32 項結果,共 50 項
-
Anti-CD52 [Campath-1H] (Ab00124-10.3-BT)
-
Anti-CD52 [Campath-1H] (Ab00124-10.3)
-
Anti-EGFR [C225 (Cetuximab)] (Ab00279-10.0-BT)
-
Anti-EGFR [C225 (Cetuximab)] (Ab00279-10.0)
-
Anti-EGFR [C225 (Cetuximab)] (Ab00279-10.3-BT)
-
Anti-EGFR [C225 (Cetuximab)] (Ab00279-10.3)
-
Anti-erbB-2 (Her-2/neu) [4D5-8 (trastuzumab)] (Ab00103-10.0-BT)
-
Anti-erbB-2 (Her-2/neu) [4D5-8 (trastuzumab)] (Ab00103-10.0)
-
Anti-IgE [huMaE11 (Omalizumab)] (Ab00717-10.0-BT)
-
Anti-IgE [huMaE11 (Omalizumab)] (Ab00717-10.0)
-
Anti-IgE [huMaE11 (Omalizumab)] (Ab00717-10.3-BT)
-
Anti-IgE [huMaE11 (Omalizumab)] (Ab00717-10.3)
-
Anti-IL-2R [Daclizumab] (Ab00187-10.0-BT)
-
Anti-IL-2R [Daclizumab] (Ab00187-10.0)
-
Anti-IL-6 receptor [rhPM-1 (Tocilizumab)] (Ab00737-10.0-BT)
-
Anti-IL-6 receptor [rhPM-1 (Tocilizumab)] (Ab00737-10.0)
